๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A southwest oncology group and cancer and leukemia group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in Adults with advanced osteosarcoma, ewing's sarcoma, and rhabdomyosarcoma

โœ Scribed by Karen Antman; John Crowley; Stanley P. Balcerzak; Raymond A. Kempf; Raymond B. Weiss; Gerald H. Clamon; Laurence H. Baker

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
102 KB
Volume
82
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis

sarcoma, or osteosarcoma.

Results

. Between 1987-1991, 81 patients were entered; 69 patients were eligible.

๐Ÿ“œ SIMILAR VOLUMES

Phase II study of 5-fluorouracil and fol
Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer: A Southwest Oncology Group study
โœ Giuseppe Colucci ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 2 views

n the article published in Cancer entitled "Phase I1 study of 5-fluoro-I uracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study,"' the authors erroneously quoted the results of our study and we request a correction. In the results of our

A phase II trial of interferon-ฮฑ and 5-f
A phase II trial of interferon-ฮฑ and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study
โœ Laurence Elias; Brent A. Blumenstein; Julie Kish; Robert C. Flanigan; James L. W ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 355 KB ๐Ÿ‘ 1 views

## BACKGROUND. Renal cell carcinoma is a common neoplasm that is often refractory to treatment. It is occasionally responsive to immunoniodulating agents including interferon-a, which enhances the effects of 5-fluorouracil upon cells. Combinations of these two drugs have been most frequently tested

Phase II trial of cis-dichlorodiamminepl
Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: A study of the cancer and acute leukemia group B
โœ F. Cavalli; Dr. W. F. Jungi; N. I. Nissen; T. F. Pajak; M. Coleman; J. F. Hollan ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 279 KB ๐Ÿ‘ 2 views

In a cooperative study of the Cancer and Acute Leukemia Group B, 27 evaluable patients with advanced malignant lymphomas were treated with 70 mg/m2 of cisdichlorodiammineplatinum(l1) (cis-platinum) once every three weeks. All patients had received extensive prior therapy. Partial remission was obtai